AC Immune SA (ACIU)
2.54
-0.24
(-8.63%)
USD |
NASDAQ |
Dec 09, 16:00
2.59
+0.05
(+1.97%)
After-Hours: 20:00
AC Immune Shareholders Equity (Quarterly): 78.48M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 4.129B |
| CRISPR Therapeutics AG | 1.916B |
| Addex Therapeutics Ltd. | 7.480M |
| NewCelX Ltd. | -- |
| Molecular Partners AG | 120.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 215.68M |
| Total Liabilities (Quarterly) | 137.20M |
| Debt to Equity Ratio | 0.0746 |
| Current Ratio | 1.157 |
| Net Debt Paydown Yield | -0.16% |